Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Operating Leases: 2019-2024

Historic Operating Leases for Neurogene (NGNE) over the last 3 years, with Dec 2024 value amounting to $9.4 million.

  • Neurogene's Operating Leases fell 45.52% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year decrease of 45.52%. This contributed to the annual value of $9.4 million for FY2024, which is 36.73% down from last year.
  • According to the latest figures from FY2024, Neurogene's Operating Leases is $9.4 million, which was down 36.73% from $14.9 million recorded in FY2023.
  • Neurogene's 5-year Operating Leases high stood at $14.9 million for FY2023, and its period low was $9.4 million during FY2024.
  • Its 2-year average for Operating Leases is $12.1 million, with a median of $12.1 million in 2023.
  • Data for Neurogene's Operating Leases shows a maximum YoY plummeted of 36.73% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Neurogene's Operating Leases stood at $14.9 million in 2023, then slumped by 36.73% to $9.4 million in 2024.